Find the Perfect Plan for Your Investment Journey
P
Latest price
52 Week Range
CA$0.07 - CA$0.34
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$14.48M |
EV | - |
Shares Outstanding | 103.45M |
Beta | 1.38 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E undefinedE | - |
P/Revenue undefinedE | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin undefinedE | - |
Net Profit Margin undefinedE | - |
ROE undefinedE | - |
ROCE | - |
DPS undefinedE | - |
Payout Ratio undefinedE | - |
Div. Yield undefinedE | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
Pharmala Biotech Holdings Inc.
MDMA
Sector
Healthcare
Industry
Biotechnology
CEO
Kadysh, Nicholas
Employees
Website
pharmala.caIPO Date
2022-01-11
Headquarters
1055 West Georgia Street P.O. Box 11117, Vancouver, British Columbia, V6E 4N7, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved